RFS
REGN icon

Richardson Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Richardson Financial Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3
Closed -$1.57K – 570
2025
Q2 		$1.57K Hold
3
– – ﹤0.01% 491
2025
Q1 		$1.9K Hold
3
– – ﹤0.01% 480
2024
Q4 		$2.14K Sell
3
-2
-40% -$1.68K ﹤0.01% 480
2024
Q3 		$5.25K Buy
5
+2
+67% +$2.23K ﹤0.01% 453
2024
Q2 		$3.15K Buy
3
+2
+200% +$1.94K ﹤0.01% 455
2024
Q1 		$962 Buy
+1
New +$951 ﹤0.01% 552

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Richardson Financial Services's REGN Position: Q3 2025 in Review

Richardson Financial Services sold out of Regeneron Pharmaceuticals (REGN) in Q3 2025, closing a stake of 3 shares — an estimated $1.57K sold.

Richardson Financial Services first reported a position in REGN in Q1 2024 and held it in 6 quarters. The position peaked at $5.25K in Q3 2024. 1,244 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

  • Richardson Financial Services reported no remaining Regeneron Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Richardson Financial Services sold 3 Regeneron Pharmaceuticals shares in Q3 2025, an estimated $1.57K.
  • Richardson Financial Services first reported a position in Regeneron Pharmaceuticals in Q1 2024 and held it in 6 quarters.
  • Richardson Financial Services's Regeneron Pharmaceuticals position peaked at $5.25K in Q3 2024.
  • 1,244 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on Richardson Financial Services's 13F filing for Q3 2025, filed 28 Oct 2025.